Ligand validation:4M4Y

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4M4Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4M4Y_NAG_E_401	56%	72%	0.142	0.912	0.59	0.49	-	-	1	0	100%	0.9333
4M4Y_NAG_A_403	44%	54%	0.113	0.837	0.43	1.33	-	4	0	0	100%	0.9333
4M4Y_NAG_C_401	37%	71%	0.2	0.898	0.48	0.65	-	-	0	0	100%	0.9333
4M4Y_NAG_A_401	21%	52%	0.222	0.833	0.76	1.08	1	1	1	0	100%	0.9333
4M4Y_NAG_C_407	15%	64%	0.215	0.777	0.52	0.85	-	1	0	0	100%	0.9333
4M4Y_NAG_A_402	14%	79%	0.326	0.88	0.43	0.44	-	-	0	0	100%	0.9333
4M4Y_NAG_E_402	13%	77%	0.293	0.839	0.33	0.58	-	-	0	0	100%	0.9333
4M4Y_NAG_C_402	6%	59%	0.363	0.795	0.66	0.89	-	-	0	0	100%	0.9333
3UBQ_NAG_G_431	72%	60%	0.098	0.92	0.53	0.97	-	2	1	0	100%	0.9333
3UBJ_NAG_G_431	70%	65%	0.094	0.912	0.53	0.81	-	1	0	0	100%	0.9333
3UBN_NAG_C_333	61%	66%	0.138	0.928	0.51	0.79	-	-	1	0	100%	0.9333
3UBE_NAG_E_333	61%	64%	0.108	0.895	0.49	0.87	-	-	1	0	100%	0.9333
3LZG_NAG_E_330	56%	19%	0.159	0.931	1.76	1.72	4	5	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.